Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
OTCMKTS:BNKL

Bionik Laboratories (BNKL) Stock Price, News & Analysis

$0.10
+0.07 (+221.54%)
(As of 10/16/2023)
Today's Range
$0.10
$0.10
50-Day Range
$0.03
$0.50
52-Week Range
$0.03
$2.90
Volume
1,700 shs
Average Volume
6,188 shs
Market Capitalization
$1.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BNKL stock logo

About Bionik Laboratories Stock (OTCMKTS:BNKL)

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.

BNKL Stock Price History

BNKL Stock News Headlines

Charles River Laboratories (CRL)
Silicon Laboratories Inc.
First human eggs grown in laboratory
Dr. Reddy's Laboratories
Mojo Media Labs
Zenotech Laboratories Ltd (ZENL)
Caplin Point Laboratories Ltd (CAPL)
Bionik laboratories appoints new CEO and CFO
See More Headlines

Company Calendar

Today
5/20/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:BNKL
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.80 million
Book Value
($0.24) per share

Miscellaneous

Free Float
8,148,000
Market Cap
$1.25 million
Optionable
Not Optionable
Beta
-0.82

Key Executives

  • Mr. Richard Paul Russo Jr. (Age 43)
    CPA, CEO, President & Director
    Comp: $343.4k
  • Mr. Michal Prywata (Age 33)
    Co-Founder & Director
    Comp: $50k
  • Mr. Daniel Gonsalves CPA (Age 40)
    Executive VP & CFO
    Comp: $237.13k
  • Mr. John Smathers
    Director of Operations

BNKL Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Bionik Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bionik Laboratories investors own include Co-Diagnostics (CODX), iBio (IBIO), Revvity (PKI), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX) and Digital Ally (DGLY).

How do I buy shares of Bionik Laboratories?

Shares of BNKL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BNKL) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners